Eli Lilly and Company dans l'actualité
Développement de médicaments pour les besoins
Tamtam a trouvé 20 articles récents sur Eli Lilly and Company.
- Transcript: Eli Lilly Q2 2026 Earnings Conference Call
- If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
- Eli Lilly (LLY) Has a Powerful Growth Flywheel Beyond Its GLP-1 Success
- Eli Lilly and the LA Dodgers: A tale of 2 dynasties
- Eli Lilly sued over stomach problems patient ties to Mounjaro and Trulicity
- Eli Lilly Quietly Expands Its Alzheimer’s Pipeline With New Early-Stage Trial
- Eli Lilly: Buy The GLP-1 Growth Premium
- Eli Lilly: Impressive Growth, Questionable Valuation (NYSE:LLY)
- This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
- Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?
- Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock
- Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug
- Eli Lilly vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
- Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
- Eli Lilly Just Announced Something Big. Here’s What It Means for Investors.
- Lilly signals move into aesthetics, looking to add products for body, skin and hair
- Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker
- Katwijk approves permits for $3 billion Eli Lilly pharmaceutical plant
- Lilly bypasses Australian pharmacies with DTC model
- How Eli Lilly Just Extended Its Lead in the Weight-Loss Drug Market
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Eli Lilly and Company ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires